Copyright © 2001 by the European Society of Cardiology.
Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure
Institute for Cardiovascular Research, Yorkshire Heart Centre, Leeds General Infirmary, Leeds, U.K.
revised November 14, 2000; accepted November 22, 2000
Abstract
Objectives This study assessed the prognostic value of peak cardiac power output, measured non-invasively during maximal cardiopulmonary exercise testing, against other exercise-derived haemodynamic variables in patients with chronic congestive heart failure.
Method and Results Two hundred and nineteen unselected, consecutive patients with congestive heart failure (166 men, mean (±SD) age of 56±13 years) who underwent maximal symptom limited cardiopulmonary treadmill exercise testing with non-invasive estimation of cardiac output using carbon dioxide re-breathing techniques, were followed-up for a mean period of 4·64 (4·47–4·82, 95% CI) years. Cardiac power output was calculated from the product of cardiac output and mean arterial blood pressure. All cause mortality was 12·3% (27 deaths). Peak and resting cardiac power output, peak mean arterial blood pressure, peak and resting cardiac output and peak VO2were all predictive of outcome on univariate analyses. Peak cardiac power output, either entered continuously or categorically with a cut-off value of 1·96 watts, was the only independent predictor of mortality (P=0·0004 for values <>1·96 watts and P=0·001 for continuous values) using multivariate analysis. A relative risk ratio of 5·08 (1·94–13·3, 95% CI) was obtained for a cardiac power output <1·96 watts.
Conclusion Peak cardiac power output is an independent predictor of mortality that can be measured non-invasively using cardiopulmonary exercise testing. It can give further prognostic power to a peak VO2in the assessment of patients with congestive heart failure.
Key Words: Chronic heart failure, cardiac power output, prognosis, non-invasive cardiopulmonary exercise testing
f1 Correspondence: Dr Lip-Bun Tan, Consultant Cardiologist, Institute for Cardiovascular Research, Yorkshire Heart Centre, Leeds General Infirmary, Leeds LS1 3EX, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Tayyareci, M. Sezer, B. Umman, S. Besisik, A. Mudun, Y. Sanli, A. Oncul, N. Gurses, D. Sargin, M. Meric, et al. Intracoronary Autologous Bone Marrow-Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach Angiology, May 1, 2008; 59(2): 145 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 P. D. Chantler, R. E. Clements, L. Sharp, K. P. George, L.-B. Tan, and D. F. Goldspink The influence of body size on measurements of overall cardiac function Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2059 - H2065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Thiele, P. Sick, E. Boudriot, K.-W. Diederich, R. Hambrecht, J. Niebauer, and G. Schuler Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock Eur. Heart J., July 1, 2005; 26(13): 1276 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Corra, A. Mezzani, E. Bosimini, and P. Giannuzzi Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*: A Prognosticating Algorithm for the Individual Patient Chest, September 1, 2004; 126(3): 942 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Fincke, J. S. Hochman, A. M. Lowe, V. Menon, J. N. Slater, J. G. Webb, T. H. LeJemtel, G. Cotter, and SHOCK Investigators Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry J. Am. Coll. Cardiol., July 21, 2004; 44(2): 340 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cotter, Y. Moshkovitz, E. Kaluski, A. J. Cohen, H. Miller, D. Goor, and Z. Vered Accurate, Noninvasive Continuous Monitoring of Cardiac Output by Whole-Body Electrical Bioimpedance Chest, April 1, 2004; 125(4): 1431 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cotter, E. Kaluski, O. Milo, A. Blatt, A. Salah, A. Hendler, R. Krakover, A. Golick, and Z. Vered LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock: A prospective randomized study Eur. Heart J., July 2, 2003; 24(14): 1287 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Hochman Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm Circulation, June 24, 2003; 107(24): 2998 - 3002. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Burniston, Y. Ng, W. A. Clark, J. Colyer, L.-B. Tan, and D. F. Goldspink Myotoxic effects of clenbuterol in the rat heart and soleus muscle J Appl Physiol, November 1, 2002; 93(5): 1824 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.A. Cooke, S.G. Williams, P. Marshall, J.K. Al-Timman, J. Shelbourne, D.J. Wright, and L.-B. Tan A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients Eur. Heart J., September 1, 2002; 23(17): 1360 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.P. Nicholls, C. O'Dochartaigh, and M.S. Riley Circulatory power--a new perspective on an old friend Eur. Heart J., August 2, 2002; 23(16): 1242 - 1245. [PDF]
|
|
|
|
 |
|
 D J Wright, S G Williams, R Riley, P Marshall, and L B Tan Is early, low level, short term exercise cardiac rehabilitation following coronary bypass surgery beneficial? A randomised controlled trial Heart, July 1, 2002; 88(1): 83 - 84. [Full Text] [PDF]
|
|
|
|
|
|
D.P. Nicholls and M.S. Riley Measuring cardiac power output--the acid test Eur. Heart J., August 2, 2001; 22(16): 1368 - 1370. [PDF]
|
|